Friday, September 15, 2017 3:41:04 PM
"I should remind you that a majority of the immunotherapy companies conducting clinical trials of CAR-T and other T-cells to treat and potentially cure patients with blood cancers and solid tumors use our products to preserve the starting material and/or final manufactured cell products.
We believe our annual revenue opportunity for a typical cell therapy candidate if approved, ranges from $500,000 to $2 million. In the first quarter of 2017, we gained 36 new direct customers, including first time direct orders from 20 new regenerative medicine customers."
They need to get the ball rolling with one.
Recent BLFS News
- BioLife Solutions to Report First Quarter 2024 Financial Results and Business Update on May 9, 2024 • PR Newswire (US) • 04/30/2024 08:12:00 PM
- BioLife Solutions Announces the Divestiture of its Stirling Freezer Business • PR Newswire (US) • 04/18/2024 12:05:00 PM
- BioLife Solutions to Present at TD Cowen and Key Bank Investor Conferences • PR Newswire (US) • 03/04/2024 01:03:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:05:54 PM
- BioLife Solutions Reports Fourth Quarter and Full Year 2023 Financial Results • PR Newswire (US) • 02/29/2024 09:03:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 10:52:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 10:51:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 10:51:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 10:51:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 10:51:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 10:50:58 PM
- BioLife Solutions to Report Fourth Quarter and Full Year 2023 Financial Results and Business Update on February 29, 2024 • PR Newswire (US) • 02/20/2024 01:03:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/02/2024 03:11:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/25/2024 10:10:38 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/24/2024 09:16:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 10:30:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 10:30:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 10:30:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 10:29:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 10:29:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 10:29:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 10:29:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 01:42:02 PM
- BioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2023 Unaudited Revenue • PR Newswire (US) • 01/08/2024 01:15:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM